本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
不入流资讯11-15 09:50
$Solid Biosciences(SLDB)$ Solid Biosciences +38% as FDA clears IND for muscular dystrophy therapy查看全文
Solid Biosciences(SLDB)11-15 21:35
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-277552 Act: 34 Size: 176 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-054388 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-054381 Size: 15 KB 网页链接查看全文
Solid Biosciences(SLDB)10-06 03:15
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-052171 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)09-07 04:45
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-046760 Size: 9 KB 网页链接查看全文
chuminhua2021-03-16 16:18
3月15日,Solid Biosciences公司报告了它所描述的 "令人鼓舞 "的中期数据,这些数据来自6名参加测试其实验性基因疗法SGT-001的I/II期IGNITE DMD试验的杜氏肌营养不良症(DMD)患者。据该公司称,腺相关病毒载体介导的基因转移疗法的早期研究结果指出,在North Star动态评估(NSAA)、6分钟...查看全文
牛唐2021-02-24 15:00
$bluebird bio(BLUE)$ 利空坐实了, FDA turns LentiGlobin suspension into a hold,后面可以观察能否迎来反转,毕竟$Solid Biosciences(SLDB)$ 的市值相当于蓝鸟的一半了。$百济神州(06160)$查看全文
牛唐2021-01-08 10:47
医药板块速评(2020.01.07)
1、$Sarepta疗法(SRPT)$ 暴跌,$Solid Biosciences(SLDB)躺枪、$Capricor疗法(CAPR)躺赢,是否有抄底或追买的机会?
2、又一药企进入NK细胞领域,是否值得布局?
$牧原股份(SZ002714)$ $恒瑞医药(SH600276)$查看全文
SM_美股投机军曹2021-01-01 12:25
$趋势投机(ZH2384794)$ @SM_美股投机军曹 $Solid Biosciences(SLDB)$
突破阻力后出现缩量小回调. 走势目前可以观察. 如果几天内无法继续上涨就是个危险信号. 下个星期可能有买入机会.查看全文
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-277552 Act: 34 Size: 176 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-061096 Act: 34 Size: 8 MB 网页链接
$Solid Biosciences(SLDB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-054381 Size: 15 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-054388 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-052171 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-046760 Size: 9 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042371 Act: 34 Size: 9 MB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-031954 Size: 7 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001193125-23-164486 Act: 34 Size: 163 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-015008 Size: 5 KB 网页链接